| Ambulatory: The Practice of Pediatric Cardiology | |
|---|---|
| 10:00 10:20 | Neurodevelopmental clinics: Who needs to go, when, and what is in it for my child? Beatrice Latal, Switzerland |
| 10:20 10:40 | Common pediatric problems still occur in children with CHD: Immunizations & noncardiac surgery LuAnn Minich, US |
| 10:40 11:00 | Etiology of and treatment of essential hypertension Elaine Urbina, US |
| 11:00 11:20 | Anticoagulation in heart disease in children and adolescents Terese Giglia, US |
| 11:20 11:40 | Smoking, passive smoke and e-cigarettes Eero Jokinen, Finland |
| 11:40 12:00 | Discussion |
| Ambulatory: When to Worry? | |
|---|---|
| 13:30 13:45 | Drugs that effect the QT, why does this happen and when to worry? Jonathan Skinner, New Zealand |
| 13:45 - 14:00 | PVCs in the structurally normal heart: what workup is needed so I do not worry? Alpay Celiker, Turkey |
| 14:00 - 14:15 | Tachycardia: Subtleties of ectopic atrial tachycardia avoiding tachycardia cardiomyopathy Ferran Rosés i Noguer, Spain |
| 14:15 - 14:30 | Congenital Heart Disease Screening: Is Pulse Oximetry Enough? Matthew Oster, US |
| 14:30 - 14:45 | Liberalizing exercise restrictions and safety letting children with CHD play Luis Serratosa, Spain |
| 14:45 - 15:00 | How to Best Assess the RV and LV myocardial performance after TOF and VSD repair? Andrew Redington, US |
| 15:00 - 15:15 | Is that LVH or HCM in my athletic patient? Michael Papadakis, UK |
| 15:15 - 15:30 | Evolving treatment strategies for HCM: Lessons I Have Learned Hartzell Scharf, US |
| Ambulatory & Genetics: Genetics/Genomics for the Practicing Cardiologist | |
|---|---|
| 10:00 10:20 | Genetics 101 How Do You Spell D-N-A? Martijn Bos, Netherlands |
| 10:20 10:40 | Genetic Testing in Pediatric Cardiology Jeffrey Towbin, US |
| 10:40 11:00 | Pharmacogenetics 101 GATCs, CYPs, VKORCs Martin Tristani, US |
| 11:00 - 11:20 | Mutation Calling: What goes into elevating a variant to "The Disease Calling Mutation? Sabine Klassen, Germany |
| 11:20 11:40 | Five Reasons NOT to Order a Genetic Test! Michael J. Ackerman, US |
| 11:40 12:00 | Discussion |
| Coronary: Congenital Coronary Artery Disease | |
|---|---|
| 13:30 13:50 | Anatomic assessment of coronary arteries: Current imaging strategies and diagnostic testing for coronary artery anatomy and perfusion in children Michael Cheung, Australia |
| 13:50 14:10 | Functional assessment of coronary arteries Shunichi Ogawa, Japan |
| 14:10 14:30 | An international perspective of anomalous origin of the coronary arteries: Are Existing Guidelines Adequate? Jan Marek, UK |
| 14:30 14:50 | Coronary artery fistulae: When to Worry and What to Do? |
| 14:50 15:10 |
Anomalous Coronary Artery from the Pulmonary Artery: Case Reviews of Typical & Atypical Presentations
Cardiology:
Surgery: Sukru Mercan, Saudi Arabia. |
| 15:10 15:30 | Surgical options for anomalous origin of the coronary arteries Pascal Vouhe, France |
| Ambulatory: Abstracts and Plenary Speaker | |
|---|---|
| 13:30 14:30 | Top 4 Ambulatory Abstracts |
| 14:45 15:15 | Plenary Lecture: "Lifetime Management of CV Risk: Investing in Your Arteries John Deanfield, UK |
| 15:15 15:30 | Discussion |
| ACC Quality Metrics: Quality Improvement in CHD at ACC | |
|---|---|
| 13:30 13:50 | Cardiac Catheterization (IMPACT Registry/RRR) Robert Vincent, US |
| 13:50 14:10 | Congenital Heart Programs Q Net Kathy Jenkins, US |
| 14:10 14:30 | NPC QIC Jeffrey Anderson, US |
| 14:30 14:50 | Transparency Efforts Rodney Franklin, UK |
| 14:50 15:30 | Discussion |
| Electrophysiology and General Ambulatory Cardiology | |
|---|---|
| 08:00 08:15 | Avoiding Red Flags in the Management of Syncope: Bringing Guidelines to the real world Mitchell Cohen, US |
| 08:15 08:30 | When chest pain is our problem: What are the clues? Juha-Mati Happonen, Finland |
| 08:30 08:45 | The evaluation of palpitations before the electrophysiologist Konrad Brockmeier, Germany |
| 08:45 09:00 | Subtle findings that predict sudden death Bryan Cannon, US |
| 09:00 - 09:15 | PVCs in postoperative congenital heart disease patients, when to worry and when to send to the EP? Nico Blom, Netherlands |
| 09:15 09:30 | ICDs for the General Cardiologist: What is new that we must know? Roland Kanter, US |
| Ambulatory: Obesity in Childhood | |
|---|---|
| 10:00 10:20 | Worldwide prevalence and pattern of childhood obesity Mercedes de Onis, Switzerland |
| 10:20 10:40 | Cardiometabolic consequences of obesity in the young Olli Raitikaru, Finland |
| 10:40 11:00 | Genetics, epigenetics and early environment on obesity and cardiovascular consequences Tom Miller, US |
| 11:00 11:20 | Can childhood obesity be managed in families? Gabriel Αngel Martos Moreno, Spain |
| 11:20 11:40 | Population strategies for childhood obesity: Future Directions Renate Oberhoffer, Germany |
| 11:40 -12:00 | Discussion |
| Ambulatory & Endocarditis/Pericarditis | |
|---|---|
| 08:00 08:20 | New endocarditis guidelines Damien Bonnet, France |
| 08:20 08:40 | Myopericarditis / perimyocarditis Richard Kirk, US |
| 08:40 09:00 | Hyper-eosinophilic endocarditis and hyper-eosinophilic syndromes Lucy Youngmin Eun, South Korea |
| 09:00 09:20 | Acute chronic pericarditis etiologies and management J. Lynn Jeffries, US |
| 09:20 09:30 | Discussion |
| 10:00 12:00 Ambulatory with PACHDA: Ambulatory Bridge Session with Pan-Arab Congenital Heart Disease Association (PACHDA) | |
|---|---|
| LV Outflow Tract Obstruction: from Fetal to Adult Life. | |
| 10:00 10:20 | Fetal Detection for LVOT Obstruction |
| 10:20 10:40 | Anatomical Variations of LV Outflow Tract Hala El Marsafawyi Egypt |
| 10:40 11:00 | Echocardiographic Imaging of LVOT Fahad Al Habshan, Saudi Arabia |
| 11:00 11:20 | Surgical Options for LVOT Zohair Al Halees, Saudi Arabia |
| 11:20 11:40 | Case Presentation Khalid Sorour, Egypt |
| 11:40 12:00 | Panel Discussion |
| 13:30 15:30 Ambulatory: Controversies in Management of Dyslipidemia in Youth | |
|---|---|
| 13:30 13:50 | Childhood Obesity: A Lifetime of Endothelial Dysfunction Beyond North America David Celermajer, Australia |
| 13:50 14:10 | Familial hypercholesterolemia: the prevalence is higher than previously estimated utility of country-wide cascade screening |
| 14:10 14:30 | Treatment of dyslipidemia in young adults: How to reconcile the pediatric vs adult guidelines. Rae-Ellen Kavey, US |
| 14:30 14:50 | Universal screening for dyslipidemia in youth should be promoted Stephen Daniels, US |
| 14:50 15:10 | Selective screening is the best approach for screening for dyslipidemia in youth |
| 15:10 15:30 | Discussion |
| 13:30 15:30 Coronary: Acquired Coronary Artery Disease | |
|---|---|
| 13:30 13:50 | Acquired coronary artery disease in adolescents and young adults: Finding the needle in the haystack. William Mahle, US |
| 13:50 14:10 | Coronary artery impairment early and late after cardiac surgery in children Hong Gu, China |
| 14:10 14:30 | Indications and outcomes of coronary artery stenting in children from post-op complications to transplant coronary artery disease Martin Schneider, Germany |
| 14:30 14:50 | Acquired coronary artery disease in adult congenital heart disease Morten Olson, Denmark |
| 14:50 15:10 | Management of Kawasaki disease to prevent coronary compromise Tohru Kobayashi, Japan |
| 15:10 15:30 | Mid- and Long-term management of coronary artery anomalies related to Kawasakis Disease |